Pink Sheet is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Esperion Therapeutics nets $74.9mm with its second IPO
02 Aug 2013
Cardiometabolic drug developer Esperion Therapeutics Inc. has netted $74.9mm through its initial public offering of 5.75mm common shares (including the overallotment) at $14, the midpoint of its proposed $13-15 range. Certain existing shareholders and affiliated entities bought a total of 1.2mm of the shares.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?